...Health info at your doorstep

Day: 24 September 2020

Johnson & Johnson Covid-19 Vaccine Enters Phase 3 Trial in U.S.

Johnson & Johnson Covid-19 Vaccine Enters Phase 3 Trial in U.S.

Coronavirus, NEWS
A fourth Covid-19 vaccine candidate has gone into the final stage of clinical trials in the U.S., with Johnson & Johnson announcing the start of its Phase 3 trial Wednesday. The drug maker follows Pfizer and Moderna, whose Phase 3 trials began in late July. AstraZeneca also started its Phase 3 vaccine trial this month, but it remains on pause in the U.S. after a participant in the U.K. was reported to have developed a spinal cord injury. The Johnson & Johnson trial is not expected to yield preliminary results for at least two months. President Donald Trump has repeatedly pressed for faster work on vaccine research — even suggesting that there could be some kind of approval before the Nov. 3 election. That timeline would be impossible, at least for Johnson & Johnson